OBJECTIVE: Vascular calcification is highly correlated with morbidity and mortality, and it is often associated with inflammation. Vitamin D may regulate vascular calcification and has been associated with cardiovascular survival benefits. METHODS AND RESULTS: We developed a macrophage/smooth muscle cell (SMC) coculture system and examined the effects of vitamin D receptor activators (VDRA), calcitriol and paricalcitol, on SMC matrix calcification. We found that treatment of SMC alone with VDRA had little effect on phosphate-induced SMC calcification in vitro. However, coculture with macrophages promoted SMC calcification, and this was strikingly inhibited by VDRA treatment. Several VDRA-induced genes, including bone morphogenetic protein-2 (BMP2), tumor necrosis factor-alpha, and osteopontin, were identified as candidate paracrine factors for the protective effect of VDRA. Of these, osteopontin was further investigated and found to contribute significantly to the inhibitory actions of VDRA on calcification in macrophage/SMC cocultures. CONCLUSIONS: The ability of VDRA to direct a switch in the paracrine phenotype of macrophages from procalcific to anticalcific may contribute to their observed cardiovascular survival benefits.
OBJECTIVE:Vascular calcification is highly correlated with morbidity and mortality, and it is often associated with inflammation. Vitamin D may regulate vascular calcification and has been associated with cardiovascular survival benefits. METHODS AND RESULTS: We developed a macrophage/smooth muscle cell (SMC) coculture system and examined the effects of vitamin D receptor activators (VDRA), calcitriol and paricalcitol, on SMC matrix calcification. We found that treatment of SMC alone with VDRA had little effect on phosphate-induced SMC calcification in vitro. However, coculture with macrophages promoted SMC calcification, and this was strikingly inhibited by VDRA treatment. Several VDRA-induced genes, including bone morphogenetic protein-2 (BMP2), tumor necrosis factor-alpha, and osteopontin, were identified as candidate paracrine factors for the protective effect of VDRA. Of these, osteopontin was further investigated and found to contribute significantly to the inhibitory actions of VDRA on calcification in macrophage/SMC cocultures. CONCLUSIONS: The ability of VDRA to direct a switch in the paracrine phenotype of macrophages from procalcific to anticalcific may contribute to their observed cardiovascular survival benefits.
Authors: Paolo Raggi; Amy Boulay; Scott Chasan-Taber; Naseem Amin; Maureen Dillon; Steven K Burke; Glenn M Chertow Journal: J Am Coll Cardiol Date: 2002-02-20 Impact factor: 24.094
Authors: Rozemarijn Vliegenthart; Monika Hollander; Monique M B Breteler; Deirdre A M van der Kuip; Albert Hofman; Matthijs Oudkerk; Jacqueline C M Witteman Journal: Stroke Date: 2002-02 Impact factor: 7.914
Authors: Jian-Su Shao; Oscar L Sierra; Richard Cohen; Robert P Mecham; Attila Kovacs; James Wang; Kathryn Distelhorst; Abraham Behrmann; Linda R Halstead; Dwight A Towler Journal: Arterioscler Thromb Vasc Biol Date: 2011-05-19 Impact factor: 8.311
Authors: Kate Ann Deuell; Andrea Callegari; Cecilia M Giachelli; Michael E Rosenfeld; Marta Scatena Journal: J Vasc Res Date: 2012-08-30 Impact factor: 1.934
Authors: Catherine Fortier; Fabrice Mac-Way; Sacha A De Serres; Karine Marquis; Pierre Douville; Simon Desmeules; Richard Larivière; Mohsen Agharazii Journal: Am J Hypertens Date: 2014-04-02 Impact factor: 2.689
Authors: Wei Ling Lau; Elizabeth M Leaf; Ming Chang Hu; Marc M Takeno; Makoto Kuro-o; Orson W Moe; Cecilia M Giachelli Journal: Kidney Int Date: 2012-08-29 Impact factor: 10.612
Authors: Timothy Ellam; Abdul Hameed; Risat ul Haque; Munitta Muthana; Martin Wilkie; Sheila E Francis; Timothy J A Chico Journal: PLoS One Date: 2014-02-19 Impact factor: 3.240